NFKB1 and neoplasm: As for PLGA-ION-R837@M, Gd@C82 nanoparticles modified with b-alanines (GF-Ala) showed an anticancer effect in vivo by activating the anti-tumor immune response and relieving the immunosuppressive TME via NF-κB/IRF5 activation [199].